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STOCHASTIC THRESHOLD MICRODOSE MODEL FOR CELL KILLING 
BY INSOLUBLE METALLIC NANOMATERIAL PARTICLES
Bobby R. Scott   Lovelace Respiratory Research Institute
 This paper introduces a novel microdosimetric model for metallic nanomaterial-parti-
cles (MENAP)-induced cytotoxicity. The focus is on the engineered insoluble MENAP
which represent a significant breakthrough in the design and development of new prod-
ucts for consumers, industry, and medicine. Increased production is rapidly occurring and
may cause currently unrecognized health effects (e.g., nervous system dysfunction, heart
disease, cancer); thus, dose-response models for MENAP-induced biological effects are
needed to facilitate health risk assessment. The stochastic threshold microdose (STM) model
presented introduces novel stochastic microdose metrics for use in constructing dose-
response relationships for the frequency of specific cellular (e.g., cell killing, mutations,
neoplastic transformation) or subcellular (e.g., mitochondria dysfunction) effects. A key
metric is the exposure-time-dependent, specific burden (MENAP count) for a given critical
target (e.g., mitochondria, nucleus). Exceeding a stochastic threshold specific burden
triggers cell death. For critical targets in the cytoplasm, the autophagic mode of death is
triggered. For the nuclear target, the apoptotic mode of death is triggered. Overall cell
survival is evaluated for the indicated competing modes of death when both apply. The
STM model can be applied to cytotoxicity data using Bayesian methods implemented via
Markov chain Monte Carlo. 
Keywords: microdosimetric model, nanomaterials, cytotoxicity
INTRODUCTION
Billions of dollars have recently been invested worldwide in nan-
otechnology research and development (Roco 2005). This is because
nanomaterials have properties that make them useful for many applica-
tions, including high conductivity, material strengthening, increasing
material durability, and altering material reactivity. Numerous nanomate-
rials are made of metals or metal oxides. The metals include iron, gold,
zinc, silver, copper, lead, cerium, zirconium, cadmium, germanium, and
selenium. Important engineered nanomaterial (ENM) now in produc-
tion include metal oxides, fullerenes, carbon nanotubes, and quantum
dots. A variety of bionanotechnologies are also being developed for bio-
medical applications. For example, ENM particles are being researched
for possible use in cancer therapy (AshaRani et al. 2009); however, not
very much is known about health risks to nanotechnology workers and
the general public for ENM particles (Donaldson et al. 2004; Moghimi et
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al. 2005; Oberdörster et al. 2005; Hardman 2006; Powell and Kanarek
2006a,b; Prabhu et al. 2009). 
ENM particles are typically defined as engineered particles having at
least one dimension <100 nanometers (nm). The particles could be
inhaled, ingested, or enter the body via uptake through the skin (intact
or wounded). 
Because of their small size, ENM particles have distinct properties
compared with the bulk form of the same materials. When inhaled, ENM
particles are efficiently deposited by diffusion-related mechanisms in all
regions of the respiratory tract. Their small size facilitates uptake into
cells and transcytosis across epithelial and endothelial cells into the blood
and lymph circulation to potentially reach targets such as bone marrow,
lymph nodes, spleen, and heart (Oberdörster et al. 2005). Translocation
to the nervous system via axons and dendrites of neurons has also been
observed (Oberdörster et al. 2005). In addition, mitochondria have been
identified as a key cytoplasmic target for uptake of ENM particles
(Oberdörster et al. 2005).
In a biological fluid, proteins associate with ENM particles, and the
amount and presentation of the proteins on the surface of the particles
can influence biological responses. Proteins compete for the nanoparti-
cle surface, leading to a protein corona that largely defines the biological
identity of the particle. Thus, knowledge of rates, affinities, and stoi-
chiometries of protein association with, and dissociation from, nanopar-
ticles is important for understanding the nature of the particle surface
seen by the functional machinery of cells. 
Potential biological effects of ENM particles include DNA damage,
mitochondrial damage, mutations, cell killing and related systemic effects
(inflammation, cancer, thrombosis, nervous system dysfunction, fibrosis
and heart disease) (Powell and Kanarek 2006a,b; AshaRani et al. 2009).
Mitochondrial damage to cells in cardiac tissue is a suspected contributor to heart
disease.
The focus of the modeling in this paper is on insoluble engineered
metallic nanomaterial particles (MENAP). In vitro studies using normal
human fibroblast have demonstrated that the cellular uptake of insoluble
engineered MENAP (silver nanoparticles) occurred mainly through
endocytosis (clathrin-mediated process and macropinocytosis), accompa-
nied by what was interpreted as a time-dependent increase in the exocy-
tosis rate (AshaRani et al. 2009). The authors however did not control for
the release of particles when cell killing occurs which may be the major
source of the particle concentration increases in the cell culture media
over time. Electron micrographs revealed that the MENAP were uni-
formly distributed in both the cytoplasm and nucleus (AshaRani et al.
2009). Thus, biological targets in both the cytoplasm and nucleus can be
at risk for being damaged by insoluble MENAP. Should it be proven (by
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new research) that the increases in time of MENAP in cell culture media
mainly relate to cell killing, then such an increase could be used as a bio-
marker for cell killing in vitro. 
The purpose of this paper is to introduce a novel mathematical model
for application to characterizing the cell killing effects of insoluble engi-
neered MENAP. Unlike deterministic models which have been applied to
soluble macroscopic size particles, stochastic models are needed for char-
acterizing biological effects of insoluble MENAP exposure of cells in the
body or in cell culture, especially for low and moderate levels of exposure
as might be expected for the general public. This paper introduces a
novel microdosimetric model. To date, microdosimetric modeling of sto-
chastic biological effects on cells has mainly been in the field of radiation
research. Here, a similar approach as has been used for radiation-
induced cytotoxicity is used for characterizing MENAP cytotoxicity. The
focus is on cell killing via one of two potentially competing modes (apop-
totic and autophagic) of programmed cell death. Different dose metrics
are proposed for the two modes of death.
Programmed cell death comprises two subtypes, as have been discov-
ered using electron microscopy. Apoptosis (type-I programmed cell
death) is characterized by condensation of the cytoplasm and preserva-
tion of organelles, essentially without autophagic degradation (Bursch et
al. 2000). On the other hand, autophagic cell death (type-II programmed
cell death) exhibits extensive autophagic degradation of Golgi apparatus,
polyribosomes and endoplasmic reticulum, which precedes nuclear
destruction (Bursch et al. 2000). It is presumed here that apoptosis is trig-
gered by nuclear DNA damage sensing pathways while autophagic cell
death is triggered by damage occurring in unspecified cytoplasmic targets
(suspected to be mitochondria). 
Because MENAP can enter and persist in the cytoplasm or translocate
to the nucleus and persist there, a microdosimetric approach should be
considered when modeling both in vitro and in vivo stochastic biological
effects of these particles. This includes effects such as mitochondria dys-
function, endoplasmic reticulum dysfunction, mutation induction, neo-
plastic transformation, cell killing, and cancer induction. Cytoplasmic
organelle dysfunction could be a contributing factor for later occurring
diseases such as cardiovascular diseases. The MENAP induced cytotoxici-
ty could also lead to debilitating diseases such as pulmonary fibrosis. This
however needs to be researched.
The model presented here does not address the transport of MENAP
to the site of the target cells or the kinetics of particle uptake by these
cells. These modeling components must be provided by other research efforts. The
focus here is on a hypothetical buildup over time of MENAP in a hypo-
thetical target-cell population and the cytotoxic consequences. The target
population is treated here as a homogenous cell population as occur in
3
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many cell culture studies (e.g., macrophages, bronchial epithelial cells,
fibroblast, etc.). In fact the model presented can be most easily applied to
cell culture studies of MENAP cytotoxicity. A more involved approach will
apply to in vivo exposures because one will need to address the particoki-
netics that lead to the transport and uptake of MENAP by the target cell
population, the macroscopic and microscopic biodistributions of parti-
cles of interest and the biological response of a heterogeneous target-cell
population.
STOCHASTIC THRESHOLD MICRODOSE MODEL FOR CELL KILLING
The Stochastic Threshold Microdose (STM) model introduced in this
section allows evaluation of the fraction of a target cell population with-
out lethal damage (survival fraction) after MENAP exposure of a given
homogeneous target cell population for a period of time t. The model
applies to insoluble MENAP. Thus, particle dissolution and subsequent
metabolism is not relevant; however, the model allows for surface charac-
teristics of MENAP being modified by the biological media that sur-
rounds them (e.g., corona formation). The STM model is based on the
individual cell specific burden (particle count) B(t) for a given critical tar-
get (e.g., nucleus), which is assumed to have a Poisson distribution. The
burden B(t) is the number of MENAP contained within a specified indi-
vidual target (e.g., nucleus) at exposure time t and depends on MENAP
dynamics (e.g., rate of uptake). When the entire cytoplasm is considered
a critical target, the burden of interest is the specific cytoplasmic burden Bc(t)
with the subscript c representing “cytoplasm”. When the nucleus is con-
sidered a critical target, the burden of interest is the specific nuclear burden
Bn(t), with the subscript n representing “nucleus”. When mitochondria in
the cytoplasm are considered the critical target, the burden of interest is
the specific mitochondrion burden Bm(t), with the subscript m represent-
ing “mitochondria”. Thus, Bm(t) is evaluated over different mitochondria
in a given cell as well as mitochondria in other target cells. In contrast,
Bn(t) is evaluated over the different target cells, since there is a single
nucleus per cell. The indicated specific burdens are stochastic (i.e., ran-
dom variables governed by the laws of probability) and exposure-time-
dependent. Thus, Bm(t) varies for different mitochondria and Bn(t) varies
for different nuclei and both have presumed Poisson distributions as pre-
viously indicated. Variation in the specific burden is expected to con-
tribute to variability in biological response to MENAP. 
The indicated three dose metrics can be represented by the covariate
vector B(t) = (Bc(t), Bn(t), Bm(t)) of specific burdens, which can be used
in dose-response modeling. The expectation (average) values of Bc(t),
Bn(t), and Bm(t) are also useful deterministic dose metrics and are respec-
tively represented by what are formally called the cytoplasmic burden Mc(t),
4
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nuclear burden Mn(t), and mitochondria burden Mm(t). The averaging applies
to a given value for the exposure time t; thus, averaging is not done over
different follow-up times. Ideally, the indicated averages would be evalu-
ated based on imaging data (e.g., using fluorescent MENAP) after expo-
sure for time t; however, the resources to achieve this may not be readily
available. In such cases, the indicated burdens (distributions and related
averages) can be estimated from dose-response data by fitting the STM
model to the data using a Bayesian approach implemented with Markov
chain Monte Carlo. This will be demonstrated in a follow-on paper to be
submitted to this journal.
The indicated averages can also be represented by a corvariate vector,
M(t) = (Mc(t), Mn(t), Mm(t)), of particle burdens, which can be used in
dose-response modeling. It is assumed that M(t) (i.e., Mc(t), Mn(t), and
Mm(t)) increases monotonically for a period of time because of particle
uptake and decrease thereafter because of cells with large MENAP bur-
dens being killed leaving a surviving cell population with lower particle
burdens as were reported by AshaRani et al. (2009) in their in vitro stud-
ies. For the presumed delayed cell killing phase, the concentration of par-
ticles in the extracellular spaces in vivo or in cell culture media is assumed
to mainly increase due to particle releases from dying cells rather than via
exocytosis as may have been incorrectly assumed by AshaRani et al. (2009). 
With the stochastic cell killing model introduced here, accumulating
a specific cytoplasmic target burden that exceeds a threshold value Nj for
target j (e.g., j = m for mitochondria) triggers the autophagic pathway to
death. Similarly, a specific nuclear burden Bn(t) that exceeds a threshold
Nn triggers the apoptotic pathway to cell death when the autophagic path
has not already been triggered. Further, both Nj and Nn are assumed to be
stochastic (i.e., differs for different cells) and to depend on the type of
MENAP and their influential characteristics. This allows for influences on
Nj and Nn of the interactions of MENAP with biological materials in the
body and in cell culture. It also allows for the varying potency (i.e., ability
to produce biological damage) of the different types of MENAP. The
potency in turn allows for evaluation of relative potency. The expectation
values for Nj and Nn are given by μj* and μn*, respectively. MENAP poten-
cy for the autophagic mode of cell death is then evaluated as 1/μj*; for the
apoptotic mode it is evaluated as 1/μn*. Thus, for mitochondria as the crit-
ical cytoplasmic target for MEMAP cell killing, potency is given by 1/μm*.
The notion of stochastic thresholds for biological effects in cells was
introduced by this author in an earlier paper (Scott 2005) that relates to
radiation-induced biological effects (apoptosis and neoplastic transfor-
mation). The existence of a stochastic threshold adds to the variability in
the biological response to MENAP exposure. The added variability is
beyond what can be attributed to variability in the microdose to the criti-
cal biological target. Thus, stochastic models are needed to address such
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variability. For this reason conventional toxicology models (which are
deterministic) that are based on macroscopic dose metrics (e.g., MENAP
concentration) may fail when attempting to account for variability in bio-
logical responses to MENAP. The variability could be rather large. In
addition, the STM model allows predicting cytotoxicity for any assigned
Poisson distribution of MENAP hits (uptakes) to the critical biological
target (e.g., mitochondria) for a given value of the particle potency. This
is not possible with conventional models.
Imaging for counting MENAP burden distributions over live cells
would allow for evaluating Mj(t) and Mn(t) for different exposure times
when the critical cytoplasmic target has been identified. The imaging
would also allow for determining whether the specific burdens of interest
have Poisson distributions; however, new research is needed to achieve this and
to develop particokinetic models for evaluating Mj(t) and Mn(t) for different
exposure times. With particokinetic models for evaluating Mj(t) and
Mn(t) and experimental data for the proportion of cells that are killed via
autophagic and apoptotic pathways, the distribution Φj(Nj) of Nj and dis-
tribution Φn(Nn) of Nn could be estimated (as a hidden Markov model
[HMM] (Rabiner 1989)) from dose-response data for cell survival using
Bayesian methods implemented using Markov chain Monte Carlo
(Gamerman 1997; Gelman et al. 1995). With Poisson distributions for the
specific burdens and threshold number of particles for causing lethality,
the respective means μj and μn of the distributions could be estimated as
free parameters when fitting the STM model to data. 
To facilitate data analysis when both the autophagic and apoptotic
modes of death operate as competing risks, the cytotoxicity data can be
adjusted to remove a competing mode of death (e.g., eliminating the
apoptotic mode to focus on the autophagic mode). This would reduce
the number of model parameters that need to be estimated for a given
analysis. The hypothetical examples presented here relate to such data.
Here an empirical function is used to estimate Mj(t) and Φj(Nj) is
assumed to represent a Poisson distribution with mean μj, which depends
on the physical, chemical, and other characteristics of the MENAP and
target cell population.. 
The cytoplasmic target burden Mj(t) is estimated here using the
monotonically increasing function Φ(t |T1/2, Cmax{V }), where:
Φ(t | T1/2,Cmax{V })= Cmax{V }{1 – exp(–[ln(2)]t/T1/2)}. (1)
The deterministic parameter Cmax{V } is the expectation value for
maximum number of particles that enter and remain in the target of
interest (cytoplasmic target) of the at-risk cell population and can be
estimated from data from cell imaging experimental studies (e.g., in vitro
studies) that focus on evaluating Mj(t) for different follow-up times for a
6
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given target cell population. The deterministic variable V is the average
target (cytoplasmic target or nucleus) volume. The deterministic vari-
able T1/2 is the half-time for target cells being MENAP-free for the peri-
od over which particle uptake progressively increases. Equation 1 can be
justified if particles from a modest size pool behave such that the num-
ber of particles, X, available for uptake decreases with exposure time t
according to the equation, dX/dt = A – kX, where A and k are constants.
Equation 1 therefore applies to the exposure time period prior to the
time point at which significant cell killing occurs. At the indicated time
point, subtle changes in Mj(t) could occur (e.g., due to loss of cells with
large burdens). An estimate of Mj(t) is Φ(t |T1/2, Cmax{Vj }), where Vj is the
cytoplasmic target volume averaged over the target cell population.
Similarly, an estimate of Mn(t) is Φ(t |T1/2, Cmax{Vn}), where Vn is corre-
sponding average nuclear volume.
In circumstances where one has a fixed exposure time but different
levels of exposure to MENAP, one can also estimate Mj(t) and Mn(t) for
the indicated exposure time based on a dose conversion factor (DCF)
which is treated as a free parameter. For example, when only the
autophagic mode of death applies (e.g., data adjusted to remove apop-
totic deaths or only this mode occurs), and the exposure concentration,
C, exposure time (t=T) product (CT) is known, then Mj(t) = DCFj*CT can
be used when fitting the STM model to real data, with DCFj as a free
parameter to be estimated for critical target j. Bayesian inference meth-
ods implemented with Markov chain Monte Carlo allow for such evalua-
tions as will be demonstrated in a subsequent paper that applies the STM
model to real data.
RESULTS
Simulations were conducted for a hypothetical in vitro study where
insoluble MENAP are injected into cell cultures and cell killing via apop-
tosis and autophagy was carefully monitored over time after injection.
The MENAP considered were monodisperse spherical particles with an
average diameter of 1 nm. Cytoplasmic particles were considered to be fil-
tered by mitochondria, reducing the number available for uptake by the
nucleus. The autophagic mode of death for this example was triggered
when the specific mitochondrion burden exceeded a Poisson distributed
value Nm with expectation value μm = 5. It was assumed that the cell killing
data were adjusted to eliminate the effect of the apoptotic pathway
deaths. The parameter Cmax{Vm} was assigned the arbitrary value of 10
MENAP on average. The parameter T1/2 was assigned the arbitrary value
of 20 minutes. These values were used for illustrative purposes and are
not based on having evaluated any real data. Figure 1 shows the pattern
of change for Mm(t) when calculations were carried out for 0, 1, 2, 4, 8,
7
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16, 32, and 64 minutes after MENAP injection. The smooth curve was
obtained using Excel smoothing software to connect the calculated
points. Adding more time points may alter the curve shape somewhat.
This is why the data points were also plotted as they will not change with
additional time points being included.
Crystal Ball (Decisioneering 2001) software was used to implement
the STM model. The assignment of μm = 5 means that on average 5
MENAP per mitochondrion would have to be exceeded for triggering
autophagic-mode lethality. A smaller value for μm may be more realistic,
depending on the susceptibility of the target cell population; however.
Figure 2 shows the simulated MENAP distributions for mitochondria for
follow-up times of 1, 2, 4, 8, 16, 32, and 64 minutes. These times are indi-
cated by T1, T2, T4,…, respectively; however, not all times could be
labeled in the figure due to cluttering so that labels for some times points
are not indicated as explained in the figure legend. Figure 3 shows the
calculated fraction (hypothetical) of target cells that did not receive
lethal mitochondrial damage (triggered by more than Nm MENAP) for
different follow-up times. Results apply to circumstances where only the
autophagic mode of cell death occurs (e.g., where data are adjusted to
eliminate the apoptotic mode). Figure 4 shows the corresponding dose-
response relationship when the mitochondria burden Mm(t) is used as the
dose metric. Results are based on 100,000 Monte Carlo realizations for
the survival fraction which were evaluated using the Excel Poisson distri-
bution cumulative probability function for Nm events (stochastic) when
the mean is Mm(t). The data points in the central curve are averages over
the 100,000 values generated. Excel smoothing functions were used for
connecting the data points in the figure. The upper curves in Figures 3
Stochastic threshold microdose model
FIGURE 1. Hypothetical pattern for the mitochondria burden, Mm(t), for a MENAP exposure sce-
nario where Equation 1 applies and Cmax{Vc} = 10 and T1/2 = 20 minutes.
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and 4 represent the 90th percentile of the distribution and the lower
curves represent the 10th percentile. These percentiles were arbitrarily
selected from the set of percentiles provided in Crystal Ball output. The
wide variability in Figure 4 relates to extra Poisson variability beyond what
can be explained based on the Poisson distribution of MENAP uptake
(hits) by mitochondria. The extra variability relates to the stochastic
B. R. Scott
FIGURE 2. Simulated cell MENAP microdose distribution (particles per mitochondrion) vs. follow-
up time after the insoluble monodisperse spherical particles are injected into cell culture. Average
burdens are evaluated based Equation 1 with Cmax{Vc}=10 and T1/2 = 20 min. From the front to back
rows, follow-up times are 1 minute (T1), 2 min, 4 min, 8 min (T8), 16 min, 32 min, and 64 min (T64). 
FIGURE 3. Simulated fraction of cells without lethal damage after exposure to insoluble MENAP par-
ticles in cell culture based on the STM model. The results apply to a data set for which only the
autophagic mode of cell death occurs (e.g., data or adjusted to eliminate the apoptotic mode
deaths). Data points on the central curve are the average of 100,000 Monte Carlo realizations. The
90th (upper curve) and 10th (lower curve) percentiles results are also presented. Model parameter
assignments are provided in the main text.
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threshold Nm for triggering the autophagic mode of cell death. The vari-
ability in the survival fraction presented in Figure 4 for Mm(t) = 1 is con-
sistent with data reported by Prabhu et al. (2009) for the in vitro cytotox-
icity of 80 nm copper nanoparticles to somatosensory neurons.
Similar results as in Figures 3 and 4 can be obtained when cell killing
via apoptosis is the focus and the biological data are adjusted to correct
for the autophagic mode of death; however, Mn(t) is expected to depend
on mean MENAP transport time, τ, through the cytoplasm to the nucle-
us. Figure 5 shows a hypothetical nuclear MENAP distribution based on
Cmax{Vn} = 4 and T1/2 still at 20 min. Assuming independence of the two
modes of death, one can then generate cell survival curves (population
averages) for both competing modes of death using the STM model as
illustrated in Figure 6. 
DISCUSSION AND CONCLUSIONS
Results in Figure 6 are based on the MENAP mitochondrial and
nuclear distributions in figures 2 and 5 and Nm having a Poisson distribu-
tion with mean μm = 5 and Nn having a Poisson distribution with mean μn
=1. The upper curve is for the apoptotic mode of death (when autophagy
is eliminated); the middle curve is for the autophagic mode of death
(when apoptosis is eliminated), and the lower curve is when both modes
of cell death apply. For independent modes of death, the respective sur-
vival fractions multiply (rather than add; a result of probability theory).
Also, the bottom curve was not obtained by multiplying the middle and
top curves (which are population averages) but rater represents averag-
ing over 100,000 results (generated from data points on many different
middle and upper curves).
FIGURE 4. Same data as in Figure 3 but plotted as a function of the mitochondria burden of MENAP. 
10
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Results similar to those presented in Figure 6 can be generated with
specific experiments that focus on application of the proposed model. It
will be important to design the studies in a way that allows evaluation of the appro-
priate particokinetics model to use for describing Mj(t) and Mn(t) for the period of
time over which particle intake by cells increases monotonically. It is reasonable
FIGURE 5. Simulated cell MENAP microdose distribution (nuclear particles per cell) vs. follow-up
time after the particles are injected into cell culture. Average nuclear burdens are evaluated based
on Equation 1 with Cmax{Vn}=4 and T1/2 = 20 min. From the front to back rows, follow-up times are 1
minute (T1), 2 min, 4 min, 8 min (T8), 16 min, 32 min, and 64 min (T64).
FIGURE 6. Simulated expected fraction of cells without lethal damage after exposure to MENAP par-
ticles in cell culture based on the STM model and the microdose distributions in Figures 2 and 5. The
upper curve relates to the apoptotic deaths due to nuclear damage when data are corrected to elim-
inate autophagic-mode effects. The middle curve is the corresponding curve for deaths via the
autophagic mode (corrected for apoptotic-mode effects). The bottom cure allows for both modes of
death. Each of the data points on the three curves are averages of 100,000 Monte Carlo realizations. 
11
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to expect that Mj(t) and Mn(t) will be found to indeed depend on Cmax(V)
(as implicated by Equation 1) and that Mn(t) will be found to depend on
τ, which may in turn be influenced by MENAP particle biological coro-
nas.
With Mj(t) and Mn(t) known (i.e., estimated) and experimental data
available for the proportion of the target cells that are killed via apopto-
sis and via autophagy over different follow-up times, Bayesian methods
(Gelman et al. 1995; Gamerman 1997) could then be employed to deter-
mine the functional form that best represents the distribution of Nj and
Nn. Should these distribution be very narrow, this would implicate fixed
values for Nj and Nn. It is anticipated that the functional form for Mj(t)
and Mn(t) and the distributions of Nj and Nn (or a fixed value for them)
may depend on physical and other characteristic of the MENAP and may
also depend on interactions of the MENAP with the cellular/tissue envi-
ronment studied (e.g., corona formation). Irrespective of the form of the
distributions Φj(Nj) and Φn(Nn), their true means (here indicated μj* and
μn*, respectively) can be used for characterizing relative potency (RP) for
two different types of MENAP using the following relationship:
RP = μk*{type-R particles}/μk*{type-T particles}. (2)
Here type-T refers to a test MENAP type and type-R refers to a reference
MENAP type and k takes on the value j for the autophagic and n for the
apoptotic modes of death, respectively.
For Poisson distributions for Nj and Nn, μj* = μj and μn* = μn. It is pos-
sible that RP estimates for cytotoxicity developed using the STM model
and in vitro data may also apply to in vivo effects that are a consequence
of cell killing for the target cell population of interest. This needs to be
investigated.
It is expected that similar RP relationships can be developed based on
applying microdosimetric models to other endpoints such as mutations,
neoplastic transformation, mitochondria dysfunction, etc.; further, these
RP values may be predictive of RP for in vivo effects such as cancer and
heart disease. However, these cross-scale extrapolations will need to be investi-
gated through a focused research program.
Experimentally-derived cell survival fractions for the autophagic,
Sj(t), and apoptotic, Sn(t), modes (i.e., adjusted to eliminate the compet-
ing mode) can be fitted using the STM model. The fitted lethality-mode-
specific survival values can then be used to obtain corresponding hazard
functions Hj(t) and Hn(t) (which are continuous cumulative hazard func-
tions) that could possibly be used to link cellular damage to tissue level
risks (e.g., pulmonary fibrosis, heart disease). For example, the tissue
level effect (e.g., fibrosis) hazard function could possibly be evaluated as
a function of Hj(t) or Hn(t) or Hj(t)+Hn(t). 
12
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The hazard functions Hj(t) and Hn(t) are formally called cell lethality
hazards as they relate to induced cytotoxicity. Reactive oxygen and nitro-
gen species may play a key role in evolution of the cell lethality hazards as
has been found for radiation exposure. The linking of cellular damage to
tissue-level risks will be addressed in subsequent research.
The indicated cell lethality hazards are evaluated as follows:
Hj(t) = –ln[Sj(t)] (3)
Hn(t) = –ln[Sn(t)]. (4)
The overall cell survival fraction, S(t), can also be evaluated using the total
cell lethality hazard H(t) (which is the sum of Hc(t) and Hn(t)) as follows:
S(t) = exp[–H(t)]. (5)
Table 1 presents plausible dose and dose-rate metrics for characteriz-
ing cellular and intracellular effects (physical stress responses) of expo-
sure of cell cultures to insoluble MENAP. For effects that relate to parti-
cle interactions with cell surface receptors, a plausible dose metric is the
product of the average MENAP concentration in the culture media mul-
tiplied by the time the cells are at risk of being damaged (here called
exposure time). The exposure time is considered important because the
number of MENAP interactions with cell surface receptors is expected to
increase over time. The derivative of the metric with respect to time gives
a plausible dose rate metric, namely the MENAP concentration in culture
media. These metrics could also be applied to characterizing biological effects of
TABLE 1. Plausible dose and dose rate metrics for characterizing cellular and intracellular effects
of insoluble MENAP in cell cultures
Biological Target Dose Metric Dose Rate Metrica
Cell surface MENAP average concentration in culture media MENAP average 
multiplied by time the target cells are at risk concentration in 
culture media
Cytoplasmic target Bj(t), Mj(t) bj(t), mj(t)
(e.g., mitochondria)
Nucleus Bn(t), Mn(t) bn(t), mn(t)
abj(t) = d(Bj(t))/dt; mj(t)= d(Mj (t))/dt; bn(t)= d(Bn(t))/dt; mn(t)= d(Mn(t))/dt. The metrics Bj(t)
and Bn(t) relate to individual targets. The metrics Mj(t) and Mn(t) are averaged over the target cell
population and can be estimated as HMM (Hidden Markov Models) using Bayesian inference meth-
ods. The distributions of Bj(t) and Bn(t) can be presumed to be Poisson distributions with expecta-
tion values Mj(t) and Mn(t), respectively, unless data indicate otherwise.
13
Scott: Stochastic threshold microdose model
Published by ScholarWorks@UMass Amherst, 2014
Stochastic threshold microdose model
441
MENAP transported in the systemic circulation in the body that result from inter-
actions with blood cell surface receptors. 
For developing dose-response relationships for biological effects that
relate to cytoplasmic organelle damage, Mj(t) (e.g., Mm(t) for mitochon-
dria damage) is a plausible dose metric (irrespective of the relevance of
Equation 1). In addition, the derivative with respect to exposure time,
mj(t) = d(Mj(t))/dt, is a plausible dose-rate metric for these effects. The
metric mj(t) is formally called the cytoplasmic target hit rate. For cases where
mitochondria are the critical target, then mm(t) would represent the mito-
chondria hit rate.
For developing dose-response relationships for biological effects that
relate to damage to targets in the nucleus (e.g., DNA, histones), Mn(t) is
a plausible dose metric (irrespective of the relevance of Equation 1). In
addition, the derivative with respect to time, mn(t) = d(Mn(t))/dt, is a plau-
sible dose-rate metric for these effects. The metric mn(t) is formally called
the nuclear hit rate.
It follows that Mn(t) and mn(t) could be used when developing dose-
response relationships for the frequency DNA single-strand breaks, DNA
double-strand breaks, chromosomal aberrations frequency, micronuclei
induction frequency, apoptosis frequency, mutation induction frequency,
and neoplastic transformation frequency. For in vivo studies, these vari-
ables could also be used for developing dose-response relationships for
cancer when evaluated for the critical target cell population; however,
particokinetics models will be needed to characterize transport of MENAP to the tar-
get cell population (e.g., cardiac tissue), uptake by the target cells, and transport to
the cell nucleus. The nuclear hit rate, mn(t), is expected to be useful for
accounting for dose-rate effects on DNA repair, mutations, neoplastic
transformation, and cancer. While only a limited number of dose metrics
are used here for MENAP, there are also other plausible dose metrics
(some correlated) as discussed below.
The focus of the modeling approach presented here was on induced
cell lethality via autophagy or apoptosis. A similar competing-risk
approach can be used to include MENAP-induced mutations, neoplastic
transformation (formation of precancerous cells), or mitochondria dys-
function. For endpoint such as mutations and neoplastic transformation
in vitro, low-level exposure to MENAP may stimulate an adaptive response
(protection against harm) whereby there is a decrease rather than an
increase in the stochastic biological effect of interest (Scott 2005). Such
effects are called protective bystander effects and may involve epigenetic sig-
naling pathways (Scott et al. 2009). Indeed, it is now considered likely that
epigenetic silencing of adaptive response genes triggered by high dose
exposure to agents such as ionizing radiation and genotoxic chemicals
plays a major role in cancer induction (Scott et al. 2009). The STM model
presented in this paper does not address protective or deleterious bystander effects.
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For some target cell populations and for a specific type of MENAP,
only one mode of cell death may apply (e.g., autophagic mode due to
mitochondrial damage). In such cases results presented will still apply;
however, information may not be available on the microdosimetric vari-
able of interest (e.g. Mm(t)). This limitation can be overcome through use
of the dose conversion factor DCFj. For example when mitochondria is
the critical target, then Mm(t) = DCFm*CT can be evaluated as a HMM
(Hidden Markov Model) given observed values of CT and the biological
effect of interest. With estimates of Mm(t), one can then generate Poisson
distributions for the mitochondrion burden as presented in Figure 2. Use
of software such as WinBUGS (Lunn et al. 2000) allows carrying out such
calculations at the same time as fitting the STM model to real data. This
will be demonstrated in a subsequent paper where the STM model is
applied to in vitro data for the cytotoxicity of MENAP.
This paper has presented a scientific basis for the use of microdosi-
metric modeling in MENAP toxicity research. For the microdosimetric
model presented to be used for in vivo applications, particokinetic mod-
els are needed to evaluate the transport and time-dependent biodistribu-
tion of insoluble MENAP particles in the body (including uptake by cells
and transport to the nucleus). Initial modeling can be based on in vitro
(particle uptake by cells) and animal (particle transport and biodistribu-
tion) studies using specific routes of exposure (e.g., inhalation or skin
application). MENAP RP (based on different MENAP characteristics) for
specific stochastic effects (cytotoxicity, mutations, neoplastic transforma-
tion, mitochondria dysfunction, etc.) can be established based on in vitro
studies and possibly applied to in vivo exposure scenarios. 
The cellular lethality hazard functions Hj(t) and Hn(t) could possibly
be used to relate cell damage to tissue damage risk when the tissue dam-
age relates to the level of cell killing (e.g., fibrosis) or cytoplasmic
organelle residual damage (e.g., mitochondria dysfunction related heart
disease) as already indicated. Proportional hazards Hj(t)/Hj(0) and
Hn(t)/Hn(0) can be used for evaluating relative risk for low-level expo-
sures. It is expected that relative risk for some stochastic effects (e.g., neo-
plastic transformation in vitro) may be predictive of relative risk for can-
cer in vivo as has been demonstrated for radiation (Redpath et al. 2001). 
It will be important to generate quantitative data for the frequency of
the specific in vivo biological effect of interest (e.g., heart disease, pul-
monary fibrosis, lung cancer) as a function of a plausible dose metric
(e.g. Mj(t), or Mn(t), or a metric that is correlated with these metrics). A
metric that would be expected to be correlated with Mj(t) and Mn(t) is the time-
dependent MENAP concentration in the target tissue (e.g., lung, heart, liver,
spleen) integrated up to time t. Other correlated metrics are discussed below. 
Table 2 summarizes formal names, methods of obtaining, and dose-
response characterization applications of the dose metrics introduced in
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this paper. Table 3 summarizes other functions and random variables that
were discussed. 
Table 4 presents plausible dose metrics that should be correlated to
Bj(t) or Bn(t). They are the specific cytoplasmic target surface area burden
SURFj (t) and the specific nuclear surface area burden SURFn(t), respectively;
also the specific cytoplasmic target mass burden MASSj(t) and the specific
nuclear mass burden MASSn(t), respectively. The expectation values for
SURFj(t) (given by Wj(t)) and MASSj(t) (given by Yj(t)) should be corre-
lated with Mj(t).The expectation values for SURFn(t) (given by Wn(t)) and
MASSn(t) (given by Yn(t)) should be correlated with Mn(t).
The deterministic variables Wj(t) and Wn(t) are formally called surface
area burdens. The deterministic variable Yj(t) and Yn(t) are formally called
mass burdens. The metrics can be represented by respective covariate vec-
tors W(t) = (Wj(t), Wn(t)) and Y(t) = (Yj(t), Yn(t)), which can be used in
dose-response modeling.
It should be clear from the above that developing the capability for
conducting a reliable risk assessment related to realistic MENAP expo-
TABLE 2. Formal names, methods of obtaining, and dose-response characterization applications of
novel MENAP dose and dose-rate metrics
Dose-response 
Characterization 
Dose Metric Formal Name Method of Obtaining Applications
Bj(t) Specific cytoplasmic Live cell imaging or Bayesian Stochastic effects that relate 
target burden (for analysis using MCMC and to damage to cytoplasmic 
target j) assuming a Poisson distribution organelles (e.g., 
with mean Mj(t) mitochondria)
Bn(t) Specific nuclear Live cell imaging or Bayesian Stochastic effects that relate 
burden analysis using MCMC and to damage to the nuclear 
assuming a Poisson distribution contents (e.g., mutations)
with mean Mn(t)
Mj(t) Cytoplasmic target Averaging of measured values Stochastic and deterministic 
burden (for target j) for Bj(t) or calculating via use effects that relate to damage 
of DCFj when conducting to cytoplasmic organelles
Bayesian analysis
Mn(t) Nuclear burden Averaging of the measured Stochastic and deterministic 
values for Bn(t) or calculating effects that relate to damage 
via use of DCFn when to nuclear contents (e.g., 
conducting Bayesian analysis DNA, histones)
mj(t) Cytoplasmic target Estimated
1 as Dose rate influence on 
hit rate (for target j) [Mj(t+Δt)–Mj(t)]/Δt stochastic effects that relate 
to cytoplasmic organelles
mn(t) Nuclear hit rate Estimated as Dose rate effects that relate 
[Mn(t+Δt)–Mn(t)]/Δt to damage to nuclear 
contents 
1The variable Δt is a small increment in exposure time.
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sure scenarios will require a multidisciplinary research team. Team mem-
bers will need to provide expertise in the following areas:
• Expertise in obtaining and analyzing time-dependent images of
MENAP in live cells.
• Expertise in quantitatively characterizing the distributions of Bj(t) and
Bn(t) over the target cell population (in vitro and in vivo).
TABLE 3. Variables and functions related to application of the STM Model to MENAP
Variable or Function Explanation
Nj Random number of cytoplasmic target particles to be exceeded to 
trigger autophagic-mode death
Nn Random number of nuclear particles to be exceeded to trigger 
apoptotic-mode death
Φj(Nj) Distribution function for Nj
Φn(Nn) Distribution function for Nn
Vj Average cytoplasmic target volume
Vn Average nuclear volume
Cmax{Vj} Maximum value for Mj(t)
Cmax{Vn} Maximum value for Mn(t)
μj* Expectation value for Nj
μn* Expectation value for Nn
μj Value for μj* when Nj has a Poisson distribution.
μn Value for μn* when Nn has a Poisson distribution.
RP MENAP relative potency
T1/2 Halftime for cells being MENAP free
TABLE 4. Other dose metrics for MENAP that should be correlated with Bj(t) or Bn(t)
Metric Formal Namea Notation Comment
Specific cytoplasmic target (e.g., SURFj(t) Total surface area (added over the 
mitochondria) surface area burdenb different particles in the cytoplasmic 
target); should be correlated with Bj(t)
Specific nuclear surface area burdenc SURFn(t) Total surface area (added over the 
different particles in the nucleus); should 
be correlated with Bn(t)
Specific cytoplasmic target (e.g., MASSj(t) Total mass load (added over the different 
mitochondria) mass burdenb particles in the cytoplasmic target); should 
be correlated with Bj(t)
Specific nuclear mass burdenc MASSn(t) Total mass load (added over the different 
particles in the nucleus); should be 
correlated with Bn(t)
aThese formal names are introduced in this paper.
bThe expectation value for this dose metric should be correlated with Mj(t).
cThe expectation value for this dose metric should be correlated with Mn(t).
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• Expertise in developing reliable particokinetic models for MENAP
transport (in vivo), biodistribution (macroscopic), uptake by critical
target cells and intracellular transport to the nucleus.
• Expertise in carrying out focused in vitro studies of MENAP-induced
molecular and cellular effects that contribute to MENAP induced
health effects: MENAP RP for different particle characteristics and for differ-
ent biological effects in vitro (e.g., DNA damage, mitochondria dysfunction,
cytotoxicity, mutation induction, neoplastic transformation, etc.) are expected to
be an important predictor of RP for specific health effects. For example, RP for
neoplastic transformation is expected to be predictive of RP for cancer induction
by MENAP.
• Expertise in carrying out focused studies using animal models of
MENAP induced health effects (e.g., nervous system dysfunction, pul-
monary fibrosis, heart disease, cancer).
• Expertise in developing dose-response models (based on reliable dose
metrics) for molecular, cellular, and systemic effects of exposure to
MENAP: The expertise should include the capability of integrating results from
molecular, cellular, and animal studies of MENAP toxicity.
• Expertise in computer code system development and implementation:
The expertise should include the ability to develop and link a dosimetric module that
allows for different exposure scenarios to modules for specific health effects (e.g., can-
cer, cardiovascular disease) of MENAP. The dosimetric module should incorporate
different sub-modules for implementing particokinetic and other models developed
by other experts including models for environmental or workplace transport of
MENAP to the human receptors, for uptake into the body, for systemic transport in
the body, for uptake by critical target cells and transport to cell organelles. The health
effects modules should incorporate dose-response models developed by other experts.
For formal risk assessments for different exposures scenarios and target populations,
a single flexible global computer code would be ideal.
It can be seen from the above that establishing a capability to carry
out reliable health risk assessment related to exposure of humans to
MENAP is a major undertaking. If not properly planned and carried out,
substantial financial and other resources could be wasted. It is important
that modelers/theoreticians and experimentalist work together in plan-
ning and carrying out MENAP toxicology research. The modeling/theo-
retical work can help guide the experimental studies and the experimen-
tal work can in turn provide valuable information for model testing and
refinement. This research implementation framework has been used
quite successfully for many years in the physical sciences. 
The development of the dose and dose rate metrics presented here
was greatly facilitated by previous microdosimetric research related to
exposure to ionizing radiation. Table 5 summarizes the correspondence
between microdosimetric and related metrics introduce in this paper for
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characterizing MENAP cytotoxicity and those used for characterizing
radiation cytotoxicity. The radiation-related microdose metrics allow pre-
dicting the expected relative potency of different types of radiation for
inducing stochastic effects such as mutations (Varma et al. 1985). The rel-
ative potency for different radiation is formally called relative biological
effectiveness. Possibly, this approach to predicting relative potency based
on first principals could also be realized for MENAP; however, in order to
achieve this goal, it will be necessary to generate experimental databases that allow
identification of key factors that influence MENAP potency. Possible influencing
factors are also listed in Table 5 and include stability, porosity, density,
shape, surface area, reactivity, hydrophobicity, and interaction with bio-
molecules in surrounding media. New research is needed to clarify the
relative importance of these factors.
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